妊娠期癌症的影像学检查
妊娠期癌症指妊娠期间至产后1年内发现的癌症,虽罕见(约1:1000妊娠)但因推迟生育和高龄产妇而增多。US和MRI为首选无电离辐射检查,碘对比剂孕期安全而钆对比剂应避免。全身MRI扩散加权序列适于筛查原发和转移灶、确定分期、识别活检靶点并指导后续癌种特异性影像。
要点
- US和MRI为妊娠期首选影像方式,均无电离辐射。
- 多数检查(乳腺X线、X线摄影、CT、99mTc硫胶体前哨淋巴结显像)辐射剂量低于确定性效应阈值。
- 碘对比剂孕期安全,钆对比剂应避免。
核心结论
- 妊娠期癌症影像需多学科团队协作,权衡母胎安全,US和MRI为首选,碘对比剂安全而钆对比剂应避免,全身MRI扩散加权序列适于筛查和分期。
研究设计与样本
- 本文为综述,提供妊娠期癌症影像分诊、安全考量、癌种特异性影像和治疗方案的更新,并附特邀评论和在线补充材料。
诊断标准与关键数值
- 妊娠期癌症定义为妊娠期间至产后1年内检测到的癌症,发生率约1:1000妊娠。
- US和MRI为首选无电离辐射影像方式。
- 多数影像检查(包括乳腺X线、X线摄影、CT和99mTc标记硫胶体前哨淋巴结分期)辐射剂量低于出现确定性副作用的阈值。
- 碘对比剂孕期安全,钆对比剂应避免。
- 全身MRI扩散加权序列适于筛查原发和转移灶、确定分期、识别活检靶点并指导进一步癌种特异性影像。
临床应用与阅片要点
- 每次检查后应提供剂量估算。
- 癌症相关症状可被妊娠期生理变化掩盖而延误诊断。
- 影像、临床管理和治疗需精心协调的多学科团队方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pregnancy-associated cancer (PAC) is defined as cancer that is detected during pregnancy and up to 1 year postpartum. Although rare (~1:1000 pregnancies), PAC is increasing owing to postponed childbearing and advanced maternal age at conception. Cancer-related symptoms masked by physiologic gestational changes may delay diagnosis. Imaging, clinical management, and treatment require a carefully choreographed multidisciplinary team approach. The risk-benefit of every imaging modality, the strategies to balance the safety of mother and fetus, and the support of the patient and family at every step are crucial. US and MRI are preferred imaging modalities that lack ionizing radiation. Radiation dose concerns should be addressed, noting that most imaging examinations (including mammography, radiography, CT, and technetium 99m-labeled sulfur colloid sentinel lymph node staging) are performed at radiation levels below thresholds at which deterministic side effects are seen. Dose estimates should be provided after each examination. The use of iodinated intravenous contrast material is safe during pregnancy, but gadolinium-based contrast material should be avoided. Accurate diagnosis and staging combined with gestational age affect decisions about surgery and chemotherapy. Whole-body MRI with diffusion-weighted sequences is ideal to screen for primary and metastatic sites, determine disease stage, identify biopsy targets, and guide further cancer site-specific imaging. The authors provide an update of the imaging triage, safety considerations, cancer-specific imaging, and treatment options for cancer in pregnancy. An invited commentary by Silverstein and Van Loon is available online. Online supplemental material is available for this article. ©RSNA, 2022.
引用
- Jha, Pōder, Glanc, et al. Imaging Cancer in Pregnancy. Radiographics. 2022. PMID: 35839139. doi:10.1148/rg.220005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。